Newland Pharmaceutical Co., Ltd. (SHE:301277)
China
· Delayed Price · Currency is CNY 12.31
-0.08 (-0.65%)
Mar 9, 2026, 4:00 PM EDT
Newland Pharmaceutical Market Cap
Newland Pharmaceutical has a market cap or net worth of 4.89 billion as of March 10, 2026. Its market cap has increased by 19.58% in one year.
Market Cap
4.89B
Enterprise Value
4.18B
Revenue
670.43M
Ranking
n/a
PE Ratio
39.51
Stock Price
12.31
Market Cap Chart
Since November 16, 2022, Newland Pharmaceutical's market cap has decreased from 5.31B to 4.89B, a decrease of -7.88%. That is a compound annual growth rate of -2.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 4.83B | 4.41% |
| Dec 31, 2025 | 4.62B | 19.35% |
| Dec 31, 2024 | 3.87B | -6.96% |
| Dec 29, 2023 | 4.16B | 8.12% |
| Dec 30, 2022 | 3.85B | -27.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jianmin Pharmaceutical Group | 4.90B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 4.75B |
| Ningbo Menovo Pharmaceutical | 4.98B |
| Zhejiang Yatai Pharmaceutical | 4.98B |
| Tibet Weixinkang Medicine | 4.67B |
| Shanghai Jiaoda Onlly Co.,Ltd | 4.64B |
| Jinling Pharmaceutical Company | 4.61B |
| Yabao Pharmaceutical Group | 4.60B |